Valentina Sancisi - Concepedia

Author

Valentina Sancisi

Azienda Sanitaria Unità Locale di Reggio Emilia ORCID

Also Known As

Sancisi, Valentina, V Sancisi, V. Sancisi, Valentina Sancisi

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Azienda Sanitaria Unità Locale di Reggio Emilia Istituti di Ricovero e Cura a Carattere Scientifico Ospedale Santa Maria University of Bologna Azienda Ospedaliera S.Maria

About

Valentina Sancisi is an author at Azienda Sanitaria Unità Locale di Reggio Emilia specializing in tumor biology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	468
2	Cell Biology	5	5	444
3	Pathology	2	2	56
4	Cancer Cell Biology	2	2	132
5	Immunology	1	1	24

Valentina Sancisi

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy Mila Gugnoni, Valentina Sancisi, Greta Gandolfi, Oncogene Cell AutophagyMedicineAutophagyCancer MetastasisCancer Biology	2016	215
TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma Greta Gandolfi, Moira Ragazzi, Andrea Frasoldati, European Journal of Endocrinology	2015	127
<i>TERT</i> Promoter Mutations in Papillary Thyroid Microcarcinomas Dario de Biase, Greta Gandolfi, Moira Ragazzi, Thyroid	2015	104
BRAFV600E Mutation Does Not Mean Distant Metastasis in Thyroid Papillary Carcinomas Valentina Sancisi, Davide Nicoli, Moira Ragazzi, The Journal of Clinical Endocrinology & Metabolism	2012	76
RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN Valentina Sancisi, Gloria Manzotti, Mila Gugnoni, Nucleic Acids Research Transcriptional RegulationDevelopmental BiologyAberrant ReactivationMedicineTranscription Regulation	2017	75
High-Sensitivity<i>BRAF</i>Mutation Analysis:<i>BRAF</i>V600E Is Acquired Early During Tumor Development but Is Heterogeneously Distributed in a Subset of Papillary Thyroid Carcinomas Dario de Biase, V. Cesari, Michela Visani, The Journal of Clinical Endocrinology & Metabolism	2014	71
The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells Giulia Gobbi, Benedetta Donati, Ítalo Faria do Valle, Oncogene Hippo PathwayCell DeathImmune Checkpoint InhibitorCell BiologyTumor Suppressor	2019	65
Allele Percentage of the<i>BRAF</i>V600E Mutation in Papillary Thyroid Carcinomas and Corresponding Lymph Node Metastases: No Evidence for a Role in Tumor Progression Greta Gandolfi, Valentina Sancisi, Federica Torricelli, The Journal of Clinical Endocrinology & Metabolism	2013	64
Cadherin 6 Is a New RUNX2 Target in TGF-β Signalling Pathway Valentina Sancisi, Greta Gandolfi, Moira Ragazzi, PLoS ONE New Runx2 TargetCancer BiologyTumor BiologyAngiogenesisThyroid Tumor Cells	2013	57
Runx2 Isoform I Controls a Panel of Proinvasive Genes Driving Aggressiveness of Papillary Thyroid Carcinomas Valentina Sancisi, Gloria Borettini, Sally Maramotti, The Journal of Clinical Endocrinology & Metabolism	2012	53

Page 1